NanoCellect accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus
Share on twitter Share on linkedin SAN DIEGO, Calif., Sept. 16, 2021 /PRNewswire/ — NanoCellect Biomedical Inc. (“NanoCellect”), the market-leading provider of microfluidic cell sorting solutions to advance cellular discoveries announced the close of $35M of financing to further accelerate commercial growth plans and new product development goals. “The past 18 months have been challenging given […]
Excision Receives FDA Clearance of IND for Phase 1/2 Trial of EBT-101 CRISPR-Based Therapeutic for Treatment of HIV
Share on twitter Share on linkedin SAN FRANCISCO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics, Inc., the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for EBT-101, a CRISPR-based therapeutic candidate in development as […]
Heritage Battery Recycling and 6K Partner to Commercialize the First Cathode-Grade Battery Recycling Network for the North American Market
North America’s foremost environmental services network teams with revolutionary plasma production manufacturer to deliver the only domestically-sourced, premium cathode-grade material from end-of-life batteries
NTx and University of Notre Dame Collaborate to Accelerate Natural Drug Discovery with Machine Learning
Share on twitter Share on linkedin RIO RANCHO, N.M.–(BUSINESS WIRE)–NTx, a biomanufacturing and bioinformatics company, today announced a collaboration with the University of Notre Dame Department of Computer Science and Engineering. Together, they are working to identify and evaluate the drug potential of previously not described natural products with a jointly developed algorithm called DruID […]
Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV
Share on twitter Share on linkedin SAN FRANCISCO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced that the Temple University team collaborating with Excision on a project, CRISPR for Cure, has received a Martin Delaney Grant from the National Institutes of […]
Aspinity Expands Executive Team and Board of Directors in Go-to-Market Drive for AnalogML
Share on twitter Share on linkedin PITTSBURGH, Aug. 17, 2021 (GLOBE NEWSWIRE) — Aspinity, the developer of analog machine learning (analogML™) chips that enable near-zero-power always-on sensing for battery-powered devices, has added a trio of industry veterans to its organization. Glen Clark, former corporate vice president and general manager of Analog Products, Cadence Design Systems […]
Zeteo Tech Awarded Competitive Grant From the National Science Foundation
Share on twitter Share on linkedin SYKESVILLE, Md.–(BUSINESS WIRE)–Zeteo Tech, the biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000. The grant will be leveraged for research and development on its […]
Voltaiq partners with Veniam to provide global solution for transferring electrified vehicle battery data
The company will leverage the leading intelligent networking platform to transfer and analyze battery information at an unprecedented scale
InterVenn Biosciences Raises $201 Million for AI-driven Glycoproteomic Platform, Liquid-Biopsy development
Share on twitter Share on linkedin SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences today announced the completion of a $201 million Series C financing. The funding round was led by new investors SoftBank Group, Heritage Provider Network, Irving Investors, Highside Capital Management, and backed by existing investors Amplify Partners, Anzu Partners, Genoa Ventures and True Ventures. […]
Excision BioTherapeutics Appoints Industry Veteran Lisa Danzig, M.D., as Chief Medical Officer
Share on twitter Share on linkedin SAN FRANCISCO, July 29, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced the appointment of Lisa Danzig, M.D., as Chief Medical Officer. “Dr. Danzig’s broad infectious disease and drug development experience will play a critical role as […]